Top

Gepubliceerd in:

01-02-2014

Depression longitudinally mediates the association of appearance concerns to ART non-adherence in HIV-infected individuals with a history of injection drug use

Auteurs: Aaron J. Blashill, Janna R. Gordon, Steven A. Safren

Gepubliceerd in: Journal of Behavioral Medicine | Uitgave 1/2014

Abstract

Appearance concerns are common among HIV-infected individuals, and previous cross-sectional and longitudinal data indicate that these concerns are associated with antiretroviral therapy (ART) non-adherence. However, to date, no known prospective data have explored the mechanism behind this relationship. Thus, the aim of the current study was to test depression severity as a prospective mediator of the relationship between appearance concerns and ART non-adherence in HIV-infected individuals with a history of injection drug use (IDU). Participants were 89 HIV-infected individuals with a history of IDU who participated in a prospective, randomized controlled trial of cognitive behavioral therapy for depression and medication adherence. Clinician-administered measures of depression severity and appearance concerns, along with electronic monitoring of ART non-adherence were included. Data were analyzed using longitudinal linear mixed-level modeling, and mediation was tested via the Monte Carlo Method of Assessing Mediation. Appearance concerns were predictive of depression severity, γ = .31, SE = .076, 95 % CI [.16, .46], t = 4.1, p = .0001, and depression severity was predictive of ART non-adherence, γ = 3.3, SE = 1.3, 95 % CI [.8, 5.8], t = 2.6, p = .01. The effect of appearance concerns on ART non-adherence, however, was significantly mediated by depression severity, γ = 1.02, 95 % CI [.21, 2.1]. Appearance concerns are associated with depression severity, which in turn is associated with ART non-adherence. Integrative interventions addressing appearance concerns, depression and ART adherence are needed, as this is one potential pathway towards worse health outcomes in HIV-infected individuals.

vorige artikel The effects of coping style on virtual reality enhanced videogame distraction in children undergoing cold pressor pain

Ambrosioni, J., Calmy, A., & Hirschel, B. (2011). HIV treatment for prevention. Journal of the International AIDS Society, 14, 28.PubMedCentralPubMedCrossRef

Ammassari, A., Antinori, A., Cozzi-Lepri, A., Trotta, M. P., Nasti, G., & Ridolfo, A. L. (2002). Relationship between HAART adherence and adipose tissue alterations. Journal of Acquired Immune Deficiency Syndromes, 31, S140–S144.PubMedCrossRef

Applebaum, A. J., Reilly, L. C., Gonzalez, J. S., Richardson, M. A., Leveroni, C. L., & Safren, S. A. (2009). The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients. AIDS Patient Care and STDs, 23, 455–462.PubMedCrossRef

Avants, S. K., Margolin, A., Warburton, L. A., Hawkins, K. A., & Shi, J. (2001). Predictors of nonadherence to HIV-related medication regimens during methadone stabilization. The American Journal on Addictions, 10, 69–78.PubMedCrossRef

Bangsberg, D. R., Perry, S., Charlebois, E. D., Clark, R. A., Roberston, M., Zolopa, A. R., et al. (2001). Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS, 15, 1181–1183.PubMedCrossRef

Bauer, D. J., Preacher, K. J., & Gil, K. M. (2006). Conceptualizing and testing random indirect effects and moderated mediation in multilevel models: New procedures and recommendations. Psychological Methods, 11, 142–163.PubMedCrossRef

Blashill, A. J., & Vander Wal, J. S. (2010). The role of body image dissatisfaction and depression on HAART adherence in HIV positive men: Tests of mediation models. AIDS and Behavior, 14, 280–288.PubMedCrossRef

Blashill, A. J., Gordon, J. R., & Safren, S. A. (2012). Appearance concerns and psychological distress among HIV-infected individuals with injection drug use histories: Prospective analyses. AIDS Patient Care and STDs, 26, 557–561.PubMedCrossRef

Carrieri, M., Chesney, M., Spire, B., Loundou, A., Sobel, A., Lepeu, G., et al. (2003). Failure to maintain adherence to HAART in a cohort of French HIV-positive injecting drug users. International Journal of Behavioral Medicine, 10, 1–14.PubMedCrossRef

Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., & Kumarasamy, N. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. The New England Journal of Medicine, 365, 493–505.PubMedCentralPubMedCrossRef

Corless, I. B., Kirksey, K. M., Kemppainen, J., Nicholas, P. K., McGibbon, C., Davis, S. M., et al. (2005). Lipodystrophy-associated symptoms and medication adherence in HIV/AIDS. AIDS Patient Care and STDs, 19, 577–586.PubMedCrossRef

Duran, S., Savès, M., Spire, B., Cailleton, V., Sobel, A., Carrieri, P. (2001). Failure to maintain long-term adherence to highly active antiretroviral therapy: The role of lipodystrophy. AIDS, 15, 2441–2444.

Genberg, G. L., Wilson, I. B., Bangsberg, D. R., Arnsten, J., Goggin, K., & Remien, R. H. (2012). Patterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North America. AIDS, 26, 1415–1423.PubMedCentralPubMedCrossRef

Giralt, M., Domingo, P., Guallar, J. P., Rodriguez de la Concepción, M. L., Alegre, M., Domingo, J. C., et al. (2006). HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV-1/HAART-associated lipodystrophy. Antiviral Therapy, 11, 729–740.PubMed

Glass, T. R., Battegay, M., Cavassini, M., De Geest, S., Furrer, H., Vernazza, P. L. (2010). Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort Study. Journal of Acquired Immune Deficiency Syndromes, 54, 197–203.

Gonzalez, J. S., Batchelder, A. W., Psaros, C., & Safren, S. A. (2011). Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes, 58, 181–187.PubMed

Guaraldi, G., Murri, R., Orlando, G., Giovanardi, C., Squillace, N., & Vandelli, M. (2008). Severity of lipodystrophy is associated with decreased health-related quality of life. AIDS Patient Care and STDs, 22, 577–585.PubMedCrossRef

Hayes, A. F. (2009). Beyond Baron and Kenny: Statistical mediation analysis in the new millennium. Communication Monographs, 76, 408–420.CrossRef

Huang, J. S., Lee, D., Becerra, K., Santos, R., Barber, E., & Mathews, W. C. (2006). Body image in men with HIV. AIDS Patient Care and STDs, 20, 668–677.PubMedCrossRef

Justice, A. C., Holmes, W., Gifford, A. L., Rabeneck, L., Zackin, R., & Sinclair, G. (2001). Development and validation of a self-completed HIV symptom index. Journal of Clinical Epidemiology, 54, S77–S90.PubMedCrossRef

Kobin, A. B., & Sheth, N. U. (2011). Levels of adherence required for virologic suppression among newer antiretroviral medications. The Annals of Pharmacotherapy, 45, 372–379.PubMedCrossRef

Kraemer, H. C., Kiernan, M., Essex, M., & Kupfer, D. J. (2008). How and why criteria defining moderators and mediators differ between the Baron & Kenny and MacArthur approaches. Health Psychology, 27, S101–S108.PubMedCentralPubMedCrossRef

Leon, A. C., Shear, M. K., Klerman, G. L., Portera, L., Rosenbaum, J. F., & Goldenberg, I. (1993). A comparison of symptom determinants of patient and clinician global ratings in patients with panic disorder and depression. Journal of Clinical Psychopharmacology, 13, 327–331.PubMedCrossRef

Liu, C., Ostrow, D., Detels, R., Hu, Z., Johnson, L., Kingsley, L., et al. (2006). Impacts of HIV infection and HAART use on quality of life. Quality of Life Research, 15, 941–949.PubMedCrossRef

Liu, H., Golin, C. E., Miller, L. G., Hays, R. D., Beck, C. K., & Sanandaji, S. (2001). A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134, 968–977.PubMedCrossRef

Llabre, M. M., Weaver, K. E., Durán, R. E., Antoni, M. H., McPherson-Baker, S., & Schneiderman, N. (2006). A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults. AIDS Patient Care & STDs, 20, 701–711.CrossRef

Low-Beer, S., Yip, B., O’Shaughnessy, M. V., Hogg, R. S., & Montaner, J. S. G. (2000). Adherence to triple therapy and viral load response. Journal of Acquired Immune Deficiency Syndromes, 23, 360.PubMed

MacKinnon, D. P., Lockwood, C. M., & Williams, J. (2004). Confidence limits for the indirect effect: Distribution of the product and resampling methods. Multivariate Behavioral Research, 39, 99–128.PubMedCentralPubMedCrossRef

Marín, A., Casado, J. L., Aranzabal, L., Moya, J., Antela, A., & Fernando, D. (2006). Validation of a specific questionnaire on psychological and social repercussions of the lipodystrophy syndrome in HIV-infected patients. Quality of Life Research, 15, 767–775.PubMedCrossRef

Martin, M., Del Cacho, E., Codina, C., Tuset, M., De Lazzari, E., & Mallolas, J. (2008). Relationship between adherence level, type of the antiretroviral regimen, and plasma HIV Type 1 RNA viral load: A prospective cohort study. AIDS Research and Human Retroviruses, 24, 1263–1268.PubMedCrossRef

Morrison, M. A., Morrison, T. G., & Sager, C. (2004). Does body satisfaction differ between gay men and lesbian women and heterosexual men and women?: A meta-analytic review. Body Image, 1, 127–138.PubMedCrossRef

Müller, M. J., Himmerich, H., Kienzle, B., & Szegedi, A. (2003). Differentiating moderate and severe depression using the Montgomery-Asberg depression rating scale (MADRS). Journal of Affective Disorders, 77, 255–260.PubMedCrossRef

National Institute of Mental Health. (1985). CGI (Clinical Global Impression) Scale. Psychopharmacological Bulletin, 21, 839–843.

Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., & Squier, C. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21–30.PubMedCrossRef

Plankey, M., Bacchetti, P., Jin, C., Grimes, B., Hyman, C., & Cohen, M. (2009). Self-perception of body fat changes and HAART adherence in the Women’s Interagency HIV Study. AIDS and Behavior, 13, 53–59.PubMedCentralPubMedCrossRef

Preacher, K. J., & Hayes, A. F. (2008). Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behavior Research Methods, 40, 879–891.PubMedCrossRef

Safren, S. A., O’Cleirigh, C. M., Bullis, J. R., Otto, M. W., Stein, M. D., & Pollack, M. H. (2012). Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected drug users: A randomized controlled trial. Journal of Consulting and Clinical Psychology, 80, 404–415.PubMedCentralPubMedCrossRef

Safren, S. A., O’Cleirigh, C., Tan, J., Raminani, S. R., Reilly, L. C., Otto, M. W., et al. (2009). A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychology, 28, 1–9.PubMedCentralPubMedCrossRef

Santos, C. P., Felipe, Y. X., Braga, P. E., Ramos, D., Lima, R. O., & Segurado, A. (2005). Self-perception of body changes in persons living with HIV/AIDS: Prevalence and associated factors. AIDS, 19, S14–S21.PubMedCrossRef

Selig, J. P., & Preacher, K. J. (2008). Monte Carlo method for assessing mediation: An interactive tool for creating confidence intervals for indirect effects [Computer software]. Available from http://quantpsy.org/

Sharma, A., Howard, A. A., Schoenbaum, E. E., Buono, D., & Webber, M. P. (2006). Body image in middle-aged HIV-infected and uninfected women. AIDS Care, 18, 998–1003.PubMedCrossRef

Sharma, A., Howard, A., Klein, R., Schoenbaum, E., Buono, D., & Webber, M. (2007). Body image in older men with or at-risk for HIV infection. AIDS Care, 19, 235–241.PubMedCentralPubMedCrossRef

Shrout, P. E., & Bolger, N. (2002). Mediation in experimental and nonexperimental studies: New procedures and recommendations. Psychological Methods, 7, 422–445.PubMedCrossRef

Spire, B., Lucas, G. M., & Carrieri, M. (2007). Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST). International Journal of Drug Policy, 18, 262–270.PubMedCrossRef

Tate, H., & George, R. (2001). The effect of weight loss on body image in HIV-positive gay men. AIDS Care, 13, 163–169.PubMedCrossRef

Theodore, P. S., Achiro, R. P., Duran, R. E. F., & Antoni, M. H. (2011). Body dissatisfaction and methamphetamine use among HIV-positive gay and bisexual men: A pilot study. Substance Use and Misuse, 46, 1745–1749.PubMedCrossRef

West, B. T. (2009). Analyzing longitudinal data with the linear mixed models procedure in SPSS. Evaluation and the Health Professions, 32, 207–228.PubMedCrossRef

Wilton, L. (2009). A preliminary study of body image and HIV sexual risk behavior in black gay and bisexual men: Implications for HIV prevention. Journal of Gay & Lesbian Social Services, 21, 309–325.CrossRef

Wingood, G. M., Diclemente, R. J., Harrington, K., & Davies, S. L. (2002). Body image and African American females’ sexual health. Journal of Women’s Health & Gender-Based Medicine, 11, 433–439.CrossRef

Titel: Depression longitudinally mediates the association of appearance concerns to ART non-adherence in HIV-infected individuals with a history of injection drug use
Auteurs: Aaron J. Blashill
Janna R. Gordon
Steven A. Safren
Publicatiedatum: 01-02-2014
Uitgeverij: Springer US
Gepubliceerd in: Journal of Behavioral Medicine / Uitgave 1/2014
Print ISSN: 0160-7715
Elektronisch ISSN: 1573-3521
DOI: https://doi.org/10.1007/s10865-012-9476-3

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 1/2014

A brief mindfulness based intervention for increase in emotional well-being and quality of life in percutaneous coronary intervention (PCI) patients: the MindfulHeart randomized controlled trial

Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms

Positive self-perceptions as a mediator of religious involvement and health behaviors in a national sample of African Americans

Anger, adiposity, and glucose control in nondiabetic adults: findings from MIDUS II

The importance of affectively-laden beliefs about health risks: the case of tobacco use and sun protection

Which symptoms matter? Self-report and observer discrepancies in repressors and high-anxious women with metastatic breast cancer